P53 and Endoglin, Two Biomarkers for Predicting HBV and Hepatocellular Carcinoma in Egyptian Patients

Journal of advanced Biomedical and Pharmaceutical Sciences
doi 10.21608/jabps.2020.24533.1075
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Egypts Presidential Specialized Council for Education and Scientific Research

Related search

Liver Cells Apoptosis Biomarkers Among Egyptian Patients With Chronic Hepatitis-C Virus and Hepatocellular Carcinoma

International Journal of Cell Science & Molecular Biology
2017English

Identification of Serologic Biomarkers for Predicting Microvascular Invasion in Hepatocellular Carcinoma

Oncotarget
Oncology
2016English

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2012English

Seroprevalence of HBV and HCV in Primary Hepatocellular Carcinoma Patients in Zimbabwe

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2009English

A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-related Hepatocellular Carcinoma

Cancer Research
Cancer ResearchOncology
2018English

Study of P53 Gene Mutations as a New Early Diagnostic Markers of Hepatocellular Carcinoma in Egyptian Patients

Madridge Journal of Oncogenesis
2018English

HBV DNA Integrates Into Upregulated ZBTB20 in Patients With Hepatocellular Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2020English

Promising Urinary Protein Biomarkers for the Early Detection of Hepatocellular Carcinoma Among High-Risk Hepatitis C Virus Egyptian Patients

Journal of Cancer
Oncology
2012English

Biomarkers in Hepatocellular Carcinoma--Letter

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy